|
|
|
|
|
Video | Thermo Fisher Scientific Bioproduction
|
Experts on this Cell & Gene live event discuss the major scientific biological advances in understanding the potential for mRNA-based immunotherapies vaccines for cancer over the last 2 years.
|
|
|
|
|
|
Webinar | Invetech
|
The high cost of producing new cell and gene therapies is one of the largest issues facing the industry. Advancements in manufacturing are driving costs down, but not at the required pace.
|
|
|
|
|
|
Video | Ori Biotech
|
Aaron Vernon from Quell Therapeutics joins to explore building robust cell therapy manufacturing, focusing on overcoming bottlenecks, smart facility design, and the crucial role of digitalization.
|
|
|
|
|
|
Video | Aliri Bioanalysis
|
Discover how this label-free whole-body QMSI combined with plasma LC-MS/MS can help identify the root causes of limited bioavailability and guide smarter optimization strategies early in development.
|
|
|
|
|
|
Video | Charter Medical
|
Charter Medical designs, develops, and manufactures single-use solutions for cell and gene therapies, rising to meet an industry demands for scalable solutions. Learn about how Charter Medical is moving healthcare innovation forward.
|
|
|
|
|
|
Webinar | Cytiva
|
Explore the significance of process development optimization and key considerations including selecting an outsourcing partner for PD projects, timing, technology, and process transfer, among others.
|
|
|
|
|
|
Video | Cell & Gene
|
On this episode of Cell & Gene: The Podcast, Host Erin Harris welcomes Monika Swietlicka, Principal, Regulatory Strategy at Halloran Consulting Group to discuss the key regulatory challenges facing cell and gene therapy companies.
|
|
|
